B

Belharra Therapeutics

48 employees

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Chemical
Research
Drug Discovery
Chemoproteomics

Date founded

2021

Funding rounds raised

Total raised

$50M

from 1 investors over 1 rounds

B

Belharra Therapeutics raised $50M on January 4, 2023

Investors: Versant Ventures

FAQ